Non Small Cell Lung Cancer (NSCLC) Therapeutics Market Size, Share, Trends and Industry Analysis by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Cancer Type (Adenocarcinoma, Squamous cell carcinoma, Large cell carcinoma), and Regional Forecast 2026-2034

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Estimated Year

2026

Forecast Period

2026-2034

Historical Period

2021-2024

Unit

Value (USD Billion)

Growth Rate

CAGR of 6.98% from 2026 to 2034

Segmentation

By Therapy

Targeted Therapy

• Bevacizumab
• Dabrafenib/Trametinib
• Erlotinib Hydrochloride
• Osimertinib
• Others

Immunotherapy

· Durvalumab

· Nivolumab

· Atezolizumab

· Pembrolizumab

Chemotherapy

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

• Others

By Cancer Type

• Adenocarcinoma

• Squamous cell carcinoma

• Large cell carcinoma

By Region

• North America (By Type, By Application, By Country)
  • U.S. (By Application)
  • Canada (By Application)
  • Mexico (By Application)
• Europe (By Type, By Application, By Country)
  • Germany (By Application)
  • U.K. (By Application)
  • France (By Application)
  • Italy (By Application)
  • Spain (By Application)
  • Rest of Europe (By Application)
• Asia Pacific (By Type, By Application, By Country)
  • China (By Application)
  • Japan (By Application)
  • India (By Application)
  • Australia (By Application)
  • New Zealand (By Application)
  • Rest of Asia Pacific (By Application)
• Southeast Asia (By Type, By Application, By Country)
  • Thailand (By Application)
  • Indonesia (By Application)
  • Vietnam (By Application)
  • Singapore (By Application)
  • Malaysia (By Application)
  • Philippines (By Application)
  • Rest of Southeast Asia (By Application)
• Latin America (By Type, By Application, By Country)
  • Brazil (By Application)
  • Argentina (By Application)
  • Rest of Latin America (By Application)
• Middle East & Africa (By Type, By Application, By Country)
  • UAE (By Application)
  • Saudi Arabia (By Application)
  • South Africa (By Application)
  • Rest of Middle East & Africa (By Application)